Werkgroep Cardiologische centra Nederland English

PARADIGM-2314 (Klaar)

A multicenter, randomized, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 compared to enalapril on morbidity and mortality in patients with chronic heart failure and reduced ejection fraction
Middel
LCZ 696 vs enalapril
Populatie
hartfalen
Fase
III
Jaar aanvang
2009
Meer informatie
ClinicalTrials.gov

PARADIGM-2314: Nieuws